Finding qualified investigator sites who can deliver patients is always a challenge – especially when the study has started and teams find themselves behind on enrollment projections. As the project goes into “rescue mode,” study teams must not only find additional sites, but also activate and engage them quickly. Learn how AstraZeneca used DrugDev technology to rescue a study in a highly competitive therapeutic area.
Join Eric Silberstein, President of DrugDev TrialNetworks, for a 12-minute tour of our innovative clinical trial optimization system, awarded “Disruptive Technology of the Year” by Partnerships in Clinical Trials 2014. The video touches on the highlights of our system including apps to streamline study startup, engage and train sites, improve conduct efficiencies, and enable faster trial closeout.